| The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA L Fang, Y Gong, AC Hooker, V Lukacova, A Rostami-Hodjegan, M Sale, ... The AAPS Journal 26 (2), 28, 2024 | 1 | 2024 |
| Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIV G Montepiedra, EM Svensson, WK Wong, AC Hooker CPT: Pharmacometrics & Systems Pharmacology 13 (2), 270-280, 2024 | | 2024 |
| Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials M Geroldinger, J Verbeeck, AC Hooker, KE Thiel, G Molenberghs, ... Orphanet Journal of Rare Diseases 18 (1), 391, 2023 | | 2023 |
| How to analyze continuous and discrete repeated measures in small-sample cross-over trials? J Verbeeck, M Geroldinger, K Thiel, AC Hooker, S Ueckert, M Karlsson, ... Biometrics 79 (4), 3998-4011, 2023 | 1 | 2023 |
| A neutral comparison of statistical methods for time-to-event analyses under non-proportional hazards F Klinglmüller, T Fellinger, F König, T Friede, AC Hooker, H Heinzl, ... arXiv preprint arXiv:2310.05622, 2023 | 2 | 2023 |
| Generation and application of avatars in pharmacometric modelling E Chasseloup, AC Hooker, MO Karlsson Journal of Pharmacokinetics and Pharmacodynamics 50 (5), 411-423, 2023 | 4 | 2023 |
| Methods for non-proportional hazards in clinical trials: A systematic review<? show [AQ ID= GQ5 POS= 12pt]?><? show [AQ ID= GQ4]?><? show [AQ ID= GQ2 POS=--12pt]?> M Bardo, C Huber, N Benda, J Brugger, T Fellinger, V Galaune, J Heinz, ... Statistical Methods in Medical Research, 09622802241242325, 2023 | 2 | 2023 |
| Establishing the suitability of model‐integrated evidence to demonstrate bioequivalence for long‐acting injectable and implantable drug products: summary of workshop Y Gong, P Zhang, M Yoon, H Zhu, A Kohojkar, AC Hooker, MP Ducharme, ... CPT: pharmacometrics & systems pharmacology 12 (5), 624-630, 2023 | 7 | 2023 |
| Evaluation of model-integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methods H Bjugård Nyberg, X Chen, M Donnelly, L Fang, L Zhao, A Hooker | | 2023 |
| Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic endpoints X Chen, H Bjugård Nyberg, M Donnelly, L Zhao, L Fang, M Karlsson, ... | | 2023 |
| Thanks to our Reviewers of 2022! L Aarons, F Agbo, K Allegaert, TM Atanackovic, R Baillie, P Bloomingdale, ... Journal of Pharmacokinetics and Pharmacodynamics 50, 75, 2023 | | 2023 |
| Mixture models in NONMEM KC Carlsson, RM Savić, A Hooker, MO Karlsson | 1 | 2023 |
| Tutorial for $ DESIGN in NONMEM: Clinical trial evaluation and optimization RJ Bauer, AC Hooker, F Mentre CPT: pharmacometrics & systems pharmacology 10 (12), 1452-1465, 2021 | 8 | 2021 |
| Metaheuristics for pharmacometrics S Kim, AC Hooker, Y Shi, GHJ Kim, WK Wong CPT: Pharmacometrics & Systems Pharmacology 10 (11), 1297-1309, 2021 | 3 | 2021 |
| Public workshop summary report on fiscal year 2021 generic drug regulatory science initiatives: data analysis and model‐based bioequivalence J Lee, Y Gong, S Bhoopathy, CE DiLiberti, AC Hooker, ... Clinical Pharmacology & Therapeutics 110 (5), 1190-1195, 2021 | 6 | 2021 |
| Pharmacometrics meets statistics—A synergy for modern drug development Y Ryeznik, O Sverdlov, EM Svensson, G Montepiedra, AC Hooker, ... CPT: Pharmacometrics & Systems Pharmacology 10 (10), 1134-1149, 2021 | 12 | 2021 |
| Bounded Integer Modeling of Symptom Scales Specific to Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia YK Lyauk, DM Jonker, AC Hooker, TM Lund, MO Karlsson The AAPS Journal 23, 1-14, 2021 | | 2021 |
| Model‐Informed Drug Development for Long‐Acting Injectable Products: Summary of American College of Clinical Pharmacology Symposium. S Sharan, L Fang, V Lukacova, X Chen, AC Hooker, MO Karlsson Clinical Pharmacology in Drug Development 10 (3), 2021 | 10 | 2021 |
| Item response theory modeling of the International Prostate Symptom Score in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia YK Lyauk, DM Jonker, TM Lund, AC Hooker, MO Karlsson The AAPS journal 22, 1-15, 2020 | 3 | 2020 |
| Integrated item response theory modeling of multiple patient-reported outcomes assessing lower urinary tract symptoms associated with benign prostatic hyperplasia YK Lyauk, TM Lund, AC Hooker, MO Karlsson, DM Jonker The AAPS Journal 22, 1-13, 2020 | 4 | 2020 |
Mats KarlssonUppsala UniversityVerified email at farmaci.uu.se
